Objective | Contact time (minutes) | Coating age (days) | Tested strains | Tested surfaces | CFU inocula used | Product tested |
---|---|---|---|---|---|---|
Efficacy testing on three types of OxiLast-coated surfaces | 60 | 0, 1, 2, 3, 5*, 6**, 7 | MRSA ATCC 33591, K. pneumoniae ATCC BAA-1705 | 20 cm2 on bedrail, cabinet, and windowsill; 2 tests 1 control each | 106 for all | OxiLast™ |
Efficacy testing of routine chlorine-based product (1000 ppm) on three types of surfaces. | 60 | 0, 1 (repeated twice each) | MRSA ATCC 33591, K. pneumoniae ATCC BAA-1705 | 20 cm2 on bedrail, cabinet, and windowsill; 2 tests 1 control each | 106 for all | Klorkleen® |
Efficacy testing of OxiLast™ against clinical isolates | 60 | 0, 1, 3 | Clinical isolates of MRSA and K. pneumoniae | 20 cm2 on bedrail and cabinet; 2 tests 1 control each | 106 for all | OxiLast™ |
Efficacy testing of OxiLast™ in presence of organic compounds*** | 60 | 0, 1, 3 | MRSA ATCC 33,591, K. pneumoniae ATCC BAA-1705 | 20 cm2 on bedrail and cabinet; 2 tests 1 control each | 106 for all | OxiLast™ |